Grifols S.A. is a leading global biopharmaceutical company specializing in the collection, processing, and transformation of human plasma into life-saving medicines. Founded in 1909 and headquartered ... Grifols S.A. is a leading global biopharmaceutical company specializing in the collection, processing, and transformation of human plasma into life-saving medicines. Founded in 1909 and headquartered in Barcelona, the firm operates across four main business lines: Bioscience, Hospital, Diagnostic, and Raw Materials. The Bioscience division is particularly notable for its focus on developing therapeutic products derived from plasma, which are essential for treating chronic and rare conditions such as immune deficiencies and bleeding disorders. Grifols maintains a significant manufacturing presence with production facilities in Europe, the United States, Mexico, and Australia, and distributes its products to more than 100 countries. By directly operating plasma donation centers worldwide, Grifols has established itself as one of the largest plasma companies, supporting resilient supply chains and innovation in transfusion medicine. The company employs more than 23,000 people and holds a strong reputation within the health technology sector, underpinning its substantial role in the global pharmaceuticals market.
In 2024, Grifols was subject to the Corporate Sustainability Reporting Directive (CSRD)'s requirements, which mandated the company to publish EU Taxonomy disclosures.
The company reported the eligibility and alignment of Turnover, Capital Expenditure (CAPEX) and Operating Expenditure (OPEX) with the EU Taxonomy, helping assess the extent to which its business activities align with Europe's environmental sustainability goals.
Grifols has also provided an activity-level breakdown of its EU Taxonomy disclosures. This granular reporting enhances transparency around which economic activities of Grifols are considered environmentally sustainable and contribute to at least one of the six environmental objectives defined under the EU Taxonomy framework.
Metric (tonnes)
2024
2023
2022
2021 - 2017
Total Taxonomy Aligned A1 Turnover
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Eligible A Turnover
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Non-Eligible B Turnover
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Metric (tonnes)
2024
2023
2022
2021 - 2017
Total Taxonomy Aligned A1 Opex
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Eligible A Opex
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Non-Eligible B Opex
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
7.4 CCM/CCA - Installation, maintenance and repair of charging stations for electric vehicles in buildings (and parking spaces attached to buildings)
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
c
0000000
7.6 CCM/CCA - Installation, maintenance and repair of renewable energy technologies
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
c
0000000
Metric (tonnes)
2024
2023
2022
2021 - 2017
Total Taxonomy Aligned A1 Capex
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Eligible A Capex
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Taxonomy Non-Eligible B Capex
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
7.4 CCM/CCA - Installation, maintenance and repair of charging stations for electric vehicles in buildings (and parking spaces attached to buildings)
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
0000000
7.6 CCM/CCA - Installation, maintenance and repair of renewable energy technologies
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
c
0000000
Limited Data Preview
You are viewing a limited preview of Grifols’s EU Taxonomy dataset. The full dataset, available for download, includes eligibility and alignment metrics for turnover, CAPEX, and OPEX across all EU Taxonomy categories (A1, A2, A, B, and A+B), at both aggregate and activity level, with historical coverage back to 2022.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Used by 1,000+ teams in finance, climate, and research
Verified Sources Behind Grifols’s EU Taxonomy Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Grifols’s data sources below and access millions more through our Disclosure Search.
a. Grifols's Integrated Report 2024
b. Grifols's Integrated Report 2023
c. Grifols's Integrated Report 2022
Insights into Grifols's Revenues from Sustainable Activities
In 2024, Grifols reported EU Taxonomy-eligible revenues of EUR 4.25 billion, representing 63.21% of its total turnover. Of this amount, EUR 0 of Grifols's revenues was classified as EU Taxonomy-aligned, indicating that 0% of the revenue-generating activities undertaken by the company substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).a
Insights into Grifols's CAPEX from Sustainable Activities
In 2024, Grifols reported EU Taxonomy-eligible CAPEX of EUR 262.60 million,representing 61.96% of its total CAPEX. Of this amount, EUR 78,436 of Grifols's CAPEX was classified as EU Taxonomy-aligned, indicating that 0.02% of the company's investments were directed toward economic activities that substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).a
Grifols's Taxonomy-Eligible Capex Over Time
Total Taxonomy Aligned A1 Capex
Total Taxonomy Eligible but Not Aligned A2 Capex
Have Grifols's increased its investment in sustainable activities over time?
Since 2022, Grifols's taxonomy-aligned capital expenditure (CAPEX)increased by 334.78%,pointing to a long-term shift toward greater investment in environmentally sustainable activities recognized under the EU Taxonomy.a, c
Compared to the previous year (2023), Grifols's taxonomy-aligned CAPEX increased by 150%,highlighting Grifols's strengthened commitment to investing in environmentally sustainable activities or improving how such investments are classified and reported under the EU Taxonomy.a, b
How much of Grifols's capital expenditure (CAPEX) is eligible under the EU Taxonomy?
In 2024, Grifols reported that EUR 262.60 million of its capital expenditure (CAPEX) was eligible under the EU Taxonomy, representing 61.96% of the company's total CAPEX. Of this amount, EUR 78,436 (0.02% of total CAPEX) was classified as Taxonomy-aligned. This means that 61.94% of Grifols's CAPEX is eligible but not aligned, indicating that these investments either did not meet the technical screening criteria, failed to comply with the Do No Significant Harm (DNSH) requirements, or lacked evidence of meeting the Minimum Safeguards (MSS).a
How much of Grifols's eligible CAPEX is aligned with the EU Taxonomy?
In 2024, Grifols reported that EUR 78,436 of its CAPEX was aligned under the EU Taxonomy, representing 0.02% of its total capital investment.a
This low alignment reflects that Grifols is beginning to transition its capital allocation toward greener investments, but still retains substantial opportunities for further alignment with sustainability goals.
Grifols's Eligibility & Alignment Overview
Grifols's Contribution to Environmental Objectives
Total Taxonomy Aligned A1 Capex
Total Taxonomy Eligible but Not Aligned A2 Capex
How is Grifols's taxonomy-aligned CAPEX distributed across the EU environmental objectives?
In 2024, Grifols reported that its taxonomy-aligned capital expenditure (CAPEX) was distributed across the following EU environmental objectivesa:
Climate Change Mitigation: 0.02%
Climate Change Adaptation: 0%
Sustainable Use and Protection of Water and Marine Resources: 0%
Transition to a Circular Economy: 0%
Pollution Prevention and Control: 0%
Protection and restoration of biodiversity and ecosystems: 0%
How much Grifols is investing in climate-related solutions?
In 2024, Grifols allocated EUR 84,759 of its CAPEX to activities contributing to the EU Taxonomy's climate-related objectives (Climate Change Mitigation and Climate Change Adaptation). This represented 0.02% of the company's total capital expenditure,indicating that Grifolshas only marginally directed its capital expenditure toward climate-related activities, suggesting limited alignment with climate objectives.a
Insights into Grifols's OPEX from Sustainable Activities
In 2024, Grifols reported EU Taxonomy-eligible OPEX of EUR 74.65 million,representing 61.98% of its total operating expenses (OPEX). Of this amount, EUR 0 of Grifols's OPEX was classified as EU Taxonomy-aligned, indicating that 0% of the company's operating expenses were directed toward economic activities that substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).a
Grifols's Taxonomy-Eligible Opex Over Time
Total Taxonomy Aligned A1 Opex
Total Taxonomy Eligible but Not Aligned A2 Opex
Have Grifols's increased its spending in sustainable activities over time?
Since 2022, Grifols's taxonomy-aligned operating expenditure (OPEX)decreased by 100%,indicating a long-term decline in sustainability-related operational spending, which may reflect shifting priorities or reduced emphasis on green initiatives.a, c
Want Full Access to Grifols's EU Taxonomy Dataset?
b
b
a
b
c
b
a
b
b
b
a
b
a